Pedigree

Benefit from over four decades of commitment to healthy patients and community involvement.
Dr. Kabara’s pioneering research in the discovery of Monolaurin in the 1960s is the basis for bringing Lauricidin to the healthcare community 12 years ago. We work with a wide spectrum of healthcare professionals (MDs, DOs, DCs, NDs, LMTs, RDs, CNCs/CNs, LAcs) and individuals, from kids through seniors.

Sharing Dr. Kabara’s Profile:
Dr. Kabara was a professor at the University of Detroit and later Michigan State University for over 30 years. His PhD from the University of Chicago involved the areas of Pharmacology and Biochemistry, with a field of expertise in the effects of fatty acids, especially the 12-carbon chain fatty acid, lauric acid. Dr. Kabara was the first to discover (circa 1966) that when lauric acid is attached to glycerin, it forms a monoglyceride known as Monolaurin. Realizing the potential health benefits for Monolaurin, Dr. Kabara coined the name for a Monolaurin supplement called, Lauricidin®. A very potent form of Monolaurin, it’s the purest and most concentrated form of Monolaurin available. Dr. Kabara has been granted over 15 scholarships, has had more than 30-research sponsors and has been awarded over 16 U.S. and foreign patents. He is credited with more than 200 publications, including book chapters or books.

In Dr. Kabara’s own words – the discovery of Monolaurin:
“Shortly after arriving (1957) at University of Detroit (Dept. of Chemistry), I began placing undergraduate students into undergraduate research projects. In the summer of 1960 a young student working for Sister Mary Stanislause (Mercy College, Detroit) was studying the nutritional needs of a protozoa, single-celled organisms, called Tetrahymena Pyriformis. Because of my interest in the structure-function of lipids, Sister [Mary Stanislause] and I decided to examine the nutritional effects of fatty acids, which were readily available in pure form. Over the years my students, colleagues and I examined a wide variety of other lipids hoping to improve on nature. Our studies eventually indicated that certain fatty acids, and especially their monoglycerides (a fatty acid attached to glycerol) found in mother’s milk had extraordinary properties. Commercially, Lauricidin® is manufactured by joining one part lauric acid to one part glycerol and the resulting new product (Lauricidin®) is purified to high and exacting standards.”

Giving Back:
To ensure that Dr. Kabara’s commitment to R&D was passed on to our communities, his family set up the Kabara Cancer Research Center at Gunderson Hospital and Kabara Institute for Entrepreneurial Studies at St. Mary’s University.